COVID-19(9) COVID-19 pandemic(8) Treatment(6) implementation(3) coronavirus disease(3) PDSA cycle(3) Clinical outcome(3) hospitalized COVID-19 patient(3) Evidence-based decision-making(3) absence(3) Evolution(3) Group-based opioid treatment (GBOT)(3) pandemic(3) interleukin 6(3) Rapid(3) interleukin 6 (IL-6)(3) performed(3) Implementation science(3) SARS-CoV-2(3) lesson(3) Local(3) tocilizumab.(3) hyperinflammatory state(3) clinical benefit(3) suggested(3) telehealth(3) Televisit(3) Tocilizumab(3) Cytokine release syndrome(3) interleukin-6 receptor(3)